Home Merck & Co., Inc. (MRK) Price Target Lowered to $65.00 at Argus
 

Keywords :   


Merck & Co., Inc. (MRK) Price Target Lowered to $65.00 at Argus

2015-11-30 07:37:30| Biotech - Topix.net

The firm presently has a "buy" rating on the stock. Argus' price target indicates a potential upside of 20.46% from the company's current price.

Tags: to price target lowered

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.10Panna diamond dream: Generations dig for fortune in India's gem town
14.10How Georgia is helping old US cars end up in Russia
14.10Atlantic Tropical Weather Outlook
14.10Eastern North Pacific Tropical Weather Outlook
13.10Watch: Why is the latest SpaceX rocket test a big deal?
13.10Atlantic Tropical Weather Outlook
13.10Eastern North Pacific Tropical Weather Outlook
13.10Atlantic Tropical Weather Outlook
More »